GC Biopharma
Korea - Yongin
PharmaceuticalFocus: Plasma Products, Vaccines
GC Biopharma is a life sciences company focused on Plasma Products, Vaccines.
Rare DiseasesInfectious DiseasesVaccines
Open Jobs
0
Pipeline & Clinical Trials
CPP-ACP
Early Caries LesionsClinical Trials (1)
NCT00670618A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 2
N/AEquia Forte
Dental Cervical Non-carious LesionClinical Trials (1)
NCT02631161Glass Hybrid Versus Composite Restorations of Non-carious Cervical Lesions
N/APERLE Sterile Smooth Opaque gel filled mammary implants
Breast ReconstructionClinical Trials (1)
NCT06013514Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
N/ACommuting with electrically assisted bicycles
Diabetes Mellitus, Type 2Clinical Trials (1)
NCT03143764Cardiorespiratory Fitness Using Electrically Assisted Bicycles
N/ALong Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma
Hepatocellular CarcinomaClinical Trials (1)
NCT01890291Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.
N/ACPP-ACP
Early Caries LesionsClinical Trials (1)
NCT00670670A Prospective, Randomized Clinical Study on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - Part 1
N/AN/A
Clinical Trials (1)
NCT05664152An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
N/AEvaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center O
Hypertension, DyslipidemiaClinical Trials (1)
NCT07084246Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
N/AA Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule
OsteoarthritisClinical Trials (1)
NCT02064634A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule
N/ASMP group
Knee OsteoarthritisClinical Trials (1)
NCT05633849Evaluation of the Effect of Pro Resolve® Sports on Treatment of Patients With Symptomatic Knee Osteoarthritis
N/Acomposite-ceramic
Dental MaterialsClinical Trials (1)
NCT04995458Clinical Evaluation of Composite-ceramic Implant-supported Posterior Crowns (Cerasmart)
N/AThe Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
Hunter SyndromeClinical Trials (1)
NCT02044692The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
N/AImmuncell-LC
Hepatocellular CarcinomaClinical Trials (1)
NCT06620510Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea
N/AOmega-3
SpondyloarthritisClinical Trials (1)
NCT04586933Nutrition in Rheumatic Diseases
N/AOmega- 3
HealthyClinical Trials (1)
NCT05621083Omega-3 Fatty Acids on Fasting and Postprandial Triglycerides (TG) Response - a Pilot Study
N/Alocal anesthesia
Dental MaterialsClinical Trials (1)
NCT04111003Fiber-reinforced Composite Core Filling in the Restoration of Endodontically Treated Molars - a Clinical Study.
N/AActive
Post-COVID ConditionClinical Trials (1)
NCT06063031Nutritional Intervention and Rehabilitation Treatment in Patients With Post-COVID Condition
N/AGCC-4401
Healthy MaleClinical Trials (1)
NCT01651234A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers
Phase 1GCC-4401C
Healthy VolunteersClinical Trials (1)
NCT01954238A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers
Phase 1GC1102
Chronic Hepatitis BClinical Trials (1)
NCT02569372A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
Phase 1MG1113
HemophiliaClinical Trials (1)
NCT05493631A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient
Phase 1GC3114
Influenza, HumanClinical Trials (1)
NCT03357263A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults
Phase 1AB-201
Breast CancerClinical Trials (1)
NCT06341647Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
Phase 1MG1113
HemophiliaClinical Trials (1)
NCT03855696A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients
Phase 1GC1102
Hepatitis BClinical Trials (1)
NCT01606163Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection
Phase 1Phase 1
Clinical Trials (1)
NCT05238532Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With ARDS
Phase 1GC1113
Healthy VolunteerClinical Trials (1)
NCT01363934To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin
Phase 1MG1111
Varicella (Chicken Pox)Clinical Trials (1)
NCT02367638Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults
Phase 1GC1118
Neoplasm MetastasisClinical Trials (1)
NCT02352571Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
Phase 1Phase 1
Clinical Trials (1)
NCT05258331Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis
Phase 1GC3107
TuberculosisClinical Trials (1)
NCT03363178Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults
Phase 1GC2129A
Healthy VolunteersClinical Trials (1)
NCT05703984A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions
Phase 1GCC2005
Lymphoma, T-CellClinical Trials (1)
NCT06699771Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Phase 1GC1123
Mucopolysaccharidosis IIClinical Trials (1)
NCT05422482A Study to Evaluate the Safety, Tolerability, PK and PD of Intracerebroventricular GC1123 in Patients with MPS Ⅱ
Phase 1GC1119
Fabry DiseaseClinical Trials (1)
NCT01653444Evaluate the Safety and Exploratory Efficacy of GC1119
Phase 1Allogeneic NK cells
Malignant LymphomasClinical Trials (1)
NCT01212341Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor
Phase 1Recombinant human apolipoprotein
Solid TumorsClinical Trials (1)
NCT01809912Safety Study of MG1102 in Patients With Solid Tumors
Phase 1GC2129A
Healthy VolunteersClinical Trials (1)
NCT05729386A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions
Phase 1GC1130A
Sanfilippo Syndrome Type AClinical Trials (1)
NCT06567769Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Phase 1GC1111_0.5mg/kg
Mucopolysaccharidosis IIClinical Trials (1)
NCT01301898To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients
Phase 1/2Immuncell-LC
Liver TransplantationClinical Trials (1)
NCT03983967Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation
Phase 1/2Quadrivalent cell-culture based influenza vaccin
InfluenzaClinical Trials (1)
NCT02249221Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)
Phase 1/2Quadrivalent influenza vaccine
InfluenzaClinical Trials (1)
NCT02121782A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)
Phase 1/2Step 1
InfluenzaClinical Trials (1)
NCT01389466Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers
Phase 1/2Rituximab
Relapsed Non Hodgkin LymphomaClinical Trials (1)
NCT03778619MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin
Phase 1/2irinotecan
Metastatic Colorectal CancerClinical Trials (1)
NCT03454620A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy
Phase 1/2HM15421/GC1134A
Fabry DisesaseClinical Trials (1)
NCT06858397A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT06997627A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adults
Phase 1/2Biological: GC3111 vaccine
TetanusClinical Trials (1)
NCT02813486Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
Phase 1/2SCD-Omegatex™
Sickle Cell DiseaseClinical Trials (1)
NCT02947100Omega-3 Fatty Acids in Sickle Cell Disease
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 50 clinical trials